Resveratrol, a known activator of Sirt1, has been reported to reduce Aβ pathology in AD mouse models through a number of mechanisms (Karuppagounder et al., 2009; Vingtdeux et al., 2010). This evidence concerns the gene SIRT1 and Alzheimer disease.